Ultragenyx Pharmaceutical Inc (NAS:RARE)
$ 42.61 1.49 (3.62%) Market Cap: 3.54 Bil Enterprise Value: 3.05 Bil PE Ratio: 0 PB Ratio: 24.36 GF Score: 70/100

Ultragenyx Pharmaceutical Inc Annual Shareholders Meeting Transcript

Jun 11, 2019 / 09:00PM GMT
Release Date Price: $58.74 (-2.93%)
Daniel G. Welch
Ultragenyx Pharmaceutical Inc. - Non-Executive Chairman

Good afternoon, ladies and gentlemen, and welcome to the 2019 Annual Meeting of Stockholders of Ultragenyx Pharmaceutical Inc. My name is Dan Welch, and I'll serve as the Chairman of the Board. I'll be presiding over this meeting.

At this time, I call the meeting to order. Emil Kakkis, our President and CEO, is present, and he will walk us through the rest of the meeting. Emil?

Emil D. Kakkis
Ultragenyx Pharmaceutical Inc. - President, CEO & Director

Thank you, Dan. Joining us today are Bill Aliski; Matt Fust; Michael Narachi; Shehnaaz Suliman; Karah Parschauer, Executive Vice President and General Counsel. Karah will act as secretary of the meeting and inspector of elections.

We're also joined today by Dan Coleman, a representative from our independent auditor, Ernst & Young LLP. During the question-and-answer period at the end of the meeting, he will be available to answer questions concerning Ernst & Young's service to the company, including the audit of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot